THE ROLE OF INTERLEUKIN-2 IN THE IMMUNOLOGICAL DEPRESSION OF PATIENTS WITH GLIOBLASTOMA

被引：0
|
作者：
NELSON, A
MERCHANT, R
FONTANA, A
YOUNG, H
机构：
[1] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT ANAT,RICHMOND,VA 23298
[2] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT NEUROSURG,RICHMOND,VA 23298
[3] UNIV HOSP ZURICH,DEPT INTERNAL MED,CH-8091 ZURICH,SWITZERLAND
来源：
JOURNAL OF NEURO-ONCOLOGY | 1984年 / 2卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：293 / 293
页数：1
相关论文
共 50 条
  • [31] MURINE INTRACEREBRAL INTERLEUKIN-2 INJECTION - PATHOLOGICAL AND IMMUNOLOGICAL EFFECTS
    YAMASAKI, T
    KIKUCHI, H
    PAINE, JT
    YAMASHITA, J
    MIYATAKE, S
    IWASAKI, K
    KOBAYASHI, H
    NAMBA, Y
    HANAOKA, M
    JOURNAL OF NEUROSURGERY, 1989, 71 (05) : 732 - 740
  • [32] Interleukin-2 is indispensable for development of immunological self-tolerance
    Klebb, G
    Autenrieth, IB
    Haber, H
    Gillert, E
    Sadlack, B
    Smith, KA
    Horak, I
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1996, 81 (03): : 282 - 286
  • [33] THE ROLE OF RECOMBINANT INTERLEUKIN-2 IN TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS B
    Novikova, A. F.
    Popova, L. L.
    Konstantinov, D. Yu.
    INFEKTSIYA I IMMUNITET, 2023, 13 (06): : 1141 - 1149
  • [34] Role of Soluble Interleukin-2 Receptor Levels in Patients with Latent Tuberculosis
    David Shitrit
    Gabriel Izbicki
    Ariella Bar-Gil Shitrit
    Meir Raz
    Jaquline Sulkes
    Mordechai Rehven Kramer
    Lung, 2006, 184 : 21 - 24
  • [35] Role of soluble interleukin-2 receptor levels in patients with latent tuberculosis
    Shitrit, D
    Izbicki, G
    Shitrit, ABG
    Raz, M
    Sulkes, J
    Kramer, MR
    LUNG, 2006, 184 (01) : 21 - 24
  • [36] SERUM INTERLEUKIN-2 AND SOLUBLE INTERLEUKIN-2 RECEPTOR LEVELS IN PATIENTS WITH CHRONIC HEADACHE
    SHIMOMURA, T
    ARAGA, S
    ESUMI, E
    AWAKI, E
    TAKAHASHI, K
    CEPHALALGIA, 1991, 11 : 285 - 286
  • [37] INTERLEUKIN-2 AND THE INTERLEUKIN-2 RECEPTOR COMPLEX
    GAULTON, GN
    WILLIAMSON, P
    LYMPHOCYTE ACTIVATION, 1994, 59 : 91 - 114
  • [38] CORTICOSTEROID INTERLEUKIN-2 INTERACTIONS - INHIBITION OF BINDING OF INTERLEUKIN-2 TO INTERLEUKIN-2 RECEPTORS
    HORST, HJ
    FLAD, HD
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1987, 68 (01): : 156 - 161
  • [39] IMMUNOLOGICAL STUDY OF HUMAN RECOMBINANT INTERLEUKIN-2 IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA
    MARUMO, K
    MURAKI, J
    UENO, M
    DEGUCHI, N
    BABA, S
    TAZAKI, H
    JOURNAL OF UROLOGY, 1987, 137 (04): : A146 - A146
  • [40] CLINICAL AND IMMUNOLOGICAL EFFECTS OF RECOMBINANT INTERLEUKIN-2 GIVEN BY REPETITIVE WEEKLY CYCLES TO PATIENTS WITH CANCER
    SONDEL, PM
    KOHLER, PC
    HANK, JA
    MOORE, KH
    ROSENTHAL, NS
    SOSMAN, JA
    BECHHOFER, R
    STORER, B
    CANCER RESEARCH, 1988, 48 (09) : 2561 - 2567
12345